Company / Return on Assets (ROA)
AMICUS THERAPEUTICS, INC. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-2.9%
FY2025
5-year range
-32.7% / -2.9%
FY2021-FY2025
Trend
+60.1%
vs FY2024
Sector context
#68 of 213
Health Care
What the data says
At -2.9%, AMICUS THERAPEUTICS, INC.'s return on assets (roa) ranks #68 of 213 in the Health Care sector. Return on Assets (ROA) has increased for 3 consecutive years, from -32.7% in FY2022 to -2.9% in FY2025.
Based on SEC 10-K filings.
-2.9% in FY2025 with a 5-year CAGR of +28.4%.
Improved from -19.5% to -2.9% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +29.8pp
- 5-Year Change
- +28.4pp
- 10-Year Change
- -
Sector benchmark
#68 of 213 in Health CareTop 32% of 213This company -2.9% Sector average -24.1%
▼
+88.2% above sector average
Key checks
Key Insights
- AMICUS THERAPEUTICS, INC.'s return on assets (roa) has grown for 3 consecutive years.
- In FY2025, return on assets (roa) increased 60.1% year-over-year.
- Currently 21.3pp above the Health Care sector average.
- Lowest return on assets (roa) in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -2.9% | +60.1% |
| FY2024 | -7.1% | +63.3% |
| FY2023 | -19.5% | +40.3% |
| FY2022 | -32.7% | -18.1% |
| FY2021 | -27.7% | +11.4% |
| FY2020 | -31.2% | +25.5% |
| FY2019 | -41.9% | +5.1% |
| FY2018 | -44.2% | +2.5% |
| FY2017 | -45.3% | -134.8% |
| FY2016 | -19.3% | -32.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026